Red Cell Half Life Determination in Patients With and Without Sickle Cell Disease

NCT04476277 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Disease
Sickle Cell Anemia

Interventions

DRUG: Biotin label

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)